Medical Cannabis for Chronic Pain: Function, Life Enjoyment, and Pain Scores
A new Minnesota medical cannabis study highlights medical cannabis chronic pain function by showing improvements in life enjoyment and daily activity. Many chronic pain patients report better function alongside pain score changes. This observational data…
CED Cannabis Science Digest: 3 Toxicology and Safety Signals Worth Watching
This digest highlights the synthetic cannabinoid toxicity review and three verified cannabis safety signals. It covers acute cardiovascular presentations and immune-cell laboratory findings. These insights refine counseling on cannabis toxicology and…
Cannabinoids in Autism, Fragile X, and Rett: What a New Systematic Review Found
A new cannabinoids pediatric autism review examined cannabinoid-based products in autism, Fragile X syndrome, and Rett syndrome. The review found possible behavioral and seizure signals but the evidence remains limited. This systematic review highlights…
CED Cannabis Science Digest: 3 Surgery, Pregnancy, and Pain Signals Worth Watching
Three additional cannabis science signals on surgery outcomes, prenatal safety messaging, and early pain-delivery research, preserved with clear evidence limits.
Cannabis Science Full Report: What a Phase 2 CBD Autism Trial Found
A 2026 phase 2 open-label cannabidiol autism trial reported early symptom improvement signals with mostly mild adverse events. The study was small and uncontrolled, limiting efficacy conclusions. This trial offers preliminary clinical insights into…
What 26 Studies and 3,598 Patients Reveal About Cannabis and PTSD
This medical cannabis PTSD scoping review examines 26 studies and 3,598 patients. The controlled-trial evidence did not support broad PTSD symptom benefit, with one narrow signal for nabilone and nightmares. The article explains what the review shows,…
CED Cannabis Science Digest: 3 Evidence and Measurement Signals Worth Watching
This digest highlights 3 evidence and measurement signals in cannabis science that help separate clinical proof from preliminary data. It covers systematic reviews, a human HIV biomarker study, and improved cannabinoid measurement methods. These signals…
CED Cannabis Science Digest: 3 Additional Clinical Signals Worth Watching
This digest highlights 3 additional cannabis science signals that sharpen clinical counseling and research endpoints. These signals include Parkinson's nonmotor symptoms, cannabis use disorder endpoints, and cannabinoid hyperemesis syndrome…
Cannabis Use in Early-Onset Psychosis: What the New Meta-Analysis Shows
A 2026 meta-analysis found cannabis use and cannabis use disorder are common in early-onset psychosis and linked to a more complicated clinical picture, but it does not prove causation.
Cannabis for Tourette Tics: What the Meta-Analysis Does and Does Not Prove
A 2026 systematic review and meta-analysis reported reductions in tic severity and premonitory urges with cannabis-based medicines in Tourette syndrome. The signal is promising, but the evidence base is still small, mixed, and not enough to settle…